The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Tuberculosis is responsible for one in four of all avoidable adult deaths in developing countries. Increased frequency and accelerated fatality of the disease among individuals infected with human immunodeficiency virus has raised worldwide concern that control programmes may be inadequate, and the emergence of multidrug-resistant strains of Mycobacterium tuberculosis has resulted in several recent fatal outbreaks in the United States. Isonicotinic acid hydrazide (isoniazid, INH) forms the core of antituberculosis regimens; however, clinical isolates that are resistant to INH show reduced catalase activity and a relative lack of virulence in guinea-pigs. Here we use mycobacterial genetics to study the molecular basis of INH resistance. A single M. tuberculosis gene, katG, encoding both catalase and peroxidase, restored sensitivity to INH in a resistant mutant of Mycobacterium smegmatis, and conferred INH susceptibility in some strains of Escherichia coli. Deletion of katG from the chromosome was associated with INH resistance in two patient isolates of M. tuberculosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An INH-resistant strain of mc2155 was shown to become sensitive upon expression of the M. tuberculosis catalase-peroxidase gene, katG, suggesting that susceptibility to INH requires the expression of katG (127).”
From Mycobacterium smegmatis: The Vanguard of Mycobacterial Research (2023) · cites this paper as [127]
Citations
Cites
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Snider, D. E., & Roper, W. L. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261011 · Cited by 382
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
The Biology of the Mycobacteria
Ratledge, C., & Stanford, J. L. (1982) · Cited by 254
Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis
Zhang, Y., Lathigra, R., Garbe, T., Catty, D., & Young, D. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb02120.x · Cited by 182
Self-citationWayne, L. G., & Diaz, G. A. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90200-9 · Cited by 173
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
JACKETT, P. S., ABER, V. R., & LOWRIE, D. B. (1978) · Journal of General Microbiology · doi:10.1099/00221287-104-1-37 · Cited by 162
Nucleotide sequence of katG, encoding catalase HPI of Escherichia coli
Triggs‐Raine, B. L., Doble, B. W., Mulvey, M. R., Sorby, P. A., & Loewen, P. C. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.9.4415-4419.1988 · Cited by 139
Mulvey, M. R., Sorby, P. A., Triggs‐Raine, B. L., & Loewen, P. C. (1988) · Gene · doi:10.1016/0378-1119(88)90498-2 · Cited by 121
Research works printed but not linked: 4
- Murray, C. J. L., Styblo, K. & Rouillon, A. Bull. Int. Union against Tuberculosis and Lung Disorders 65, 6–24 (1990).
- Cohn, M. L., Kovitz, C., Oda, U. & Middlebrook, G. Am. Rev. Tuberc. 70, 641–664 (1954).
- Youatt, J. Am. Rev. respir. Dis. 99, 729–749 (1969).
- Heym, B. & Cole, S. T. Res. Microbiol. (in the press).
Cited by
Items 701–800 of 1,000
Cingolani, A., Antinori, A., Sanguinetti, M., Gillini, L., Luca, A. D., Posteraro, B., Ardito, F., Fadda, G., & Ortona, L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314677 · Cited by 19
Strategies for New Drug Development
Young, D. B. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch32 · Cited by 19
Self-citationWang, S., Wang, K., Song, K., Lai, Z. W., Li, P., Li, D., Sun, Y., Mei, Y., Xu, C., & Liao, M. (2024) · Nature Communications · doi:10.1038/s41467-024-51948-9 · Cited by 18
Alcaraz, M., Edwards, T. E., & Kremer, L. (2023) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2224563 · Cited by 19
Harrison, G. A., Wang, E. R., Cho, K., Mreyoud, Y., Sarkar, S., Almqvist, F., Patti, G. J., & Stallings, C. L. (2024) · mBio · doi:10.1128/mbio.02968-23 · Cited by 20
Billows, N., Phelan, J. E., Xia, D., Peng, Y., Clark, T. G., & Chang, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-62946-8 · Cited by 19
Tuberculosis: Is the landscape changing?
Khatua, S., Geltemeyer, A. M., & Gourishankar, A. (2016) · Pediatric Research · doi:10.1038/pr.2016.205 · Cited by 18
Verma, R., Boshoff, H. I., Arora, K., Bairy, I., Tiwari, M., Bhat, V. G., & Shenoy, G. G. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.07.035 · Cited by 18
Iqbal, K., Abdelnasir, S., Anwar, A., Iqbal, K. M., Shah, M. R., Anwar, A., Siddiqui, R., & Khan, N. A. (2020) · Antibiotics · doi:10.3390/antibiotics9050276 · Cited by 18
Tuberculosis: current scenario, drug targets, and future prospects
Bose, P., Harit, A. K., Das, R., Sau, S., Iyer, A. K., & Kashaw, S. K. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02691-5 · Cited by 19
Inter‐ and intramolecular domain interactions of the catalase‐peroxidase KatG from M. tuberculosis
Wilming, M., & Johnsson, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03179-9 · Cited by 20
Analysis of isoniazid-resistant transposon mutants of Mycobacterium smegmatis
Billman‐Jacobe, H., Sloan, J., & Coppel, R. L. (1996) · FEMS Microbiology Letters · doi:10.1016/0378-1097(96)00336-9 · Cited by 18
Lu, X., Chen, Y., & You, Q. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00926.x · Cited by 18
Fármacos con actividad frente a Mycobacterium tuberculosis
Coll, P. (2003) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(03)72945-0 · Cited by 50
Guo, J.-H., Xiang, W., Zhao, Q., Luo, T., Huang, M. Z., Zhang, J., Zhao, J., Yang, Z., & Sun, Q. (2008) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2008.264 · Cited by 18
Brosse, N., Pinto, M., & Jamart‐Grégoire, B. (1998) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a807230b · Cited by 18
katGI and katGII encode two different catalases-peroxidases in Mycobacterium fortuitum
Menendez, M. C., Aínsa, J. A., Martín, C., & García, M. J. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.22.6880-6886.1997 · Cited by 18
Lee, S. H., Choi, H. B., Yu, S. Y., Chang, U. J., Kim, C. K., & Kim, H. J. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.5.487 · Cited by 17
Swanepoel, C. C., & Loots, D. T. (2014) · Disease Markers · doi:10.1155/2014/124218 · Cited by 19
Ennassiri, W., Jaouhari, S., Sabouni, R., Cherki, W., Charof, R., Filali‐Maltouf, A., & Lahlou, O. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.09.017 · Cited by 17
KatG-Mediated Oxidation Leading to Reduced Susceptibility of Bacteria to Kanamycin
Loewen, P. C., Silva, P. M. D., Donald, L. J., Switala, J., Villanueva, J., Fita, I., & Kumar, A. (2018) · ACS Omega · doi:10.1021/acsomega.8b00356 · Cited by 17
Jayaraman, M., & Ramadas, K. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107768 · Cited by 17
Abdulhamid, A., Awad, T. A., Ahmed, A. E., Koua, F., & Ismail, A. M. (2021) · Microbiology Research · doi:10.3390/microbiolres12010001 · Cited by 17
Svistunenko, D. A., Worrall, J. A. R., Chugh, S. B., Haigh, S. C., Ghiladi, R. A., & Nicholls, P. (2012) · Biochimie · doi:10.1016/j.biochi.2012.02.021 · Cited by 19
Silva, J., Mesquita, A. R., & Ximenes, E. A. (2009) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762009000400008 · Cited by 17
QSAR based therapeutic management of M. tuberculosis
Ahamad, S., Rahman, S., Khan, F. I., Dwivedi, N., Ali, S., Kim, J., & Hassan, M. I. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0914-1 · Cited by 18
Purkan, P., Ihsanawati, I., Natalia, D., Syah, Y. M., RETNONINGRUM, D. S., & Siswanto, I. (2018) · PubMed Central · Cited by 17
Kruh‐Garcia, N. A., Rawat, R., Ruzsicska, B. P., & Tonge, P. J. (2007) · Protein Science · doi:10.1110/ps.062749007 · Cited by 17
Diagnóstico rápido de la tuberculosis. Detección de mecanismos de resistencia
Viñuelas‐Bayón, J., Vitoria, M. A., & Samper, S. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2017.01.015 · Cited by 17
Host-mediated modification of PvuII restriction in Mycobacterium tuberculosis
van Soolingen, D., de Haas, P. E., Blumenthal, R., Kremer, K., Sluijter, M., Pijnenburg, J., Schouls, L. M., Thole, J. E. R., Dessens-Kroon, M., van Embden, J. D., et al. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.78-84.1996 · Cited by 17
Isoniazid Induces Its Own Resistance in Nonreplicating Mycobacterium tuberculosis
Siddiqi, S. H., Takhar, P., Baldeviano, C., Glover, W. A., & Zhang, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00086-07 · Cited by 19
Self-citationKatG as Counterselection Marker for Nontuberculous Mycobacteria
Gagliardi, A., Selchow, P., Luthra, S., Schäfle, D., Schulthess, B., & Sander, P. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02508-19 · Cited by 17
Rapid molecular screening for multidrug‐resistant tuberculosis in a resource‐limited region of China
Zhang, D., Liu, B., Wang, Y., & Pang, Y. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12359 · Cited by 16
Li, G., Zhang, J., Jiang, Y., Zhao, L., Liu, H., Li, M., Zhao, X., & Wan, K. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.08.005 · Cited by 16
Aragaw, W. W., Lee, B. M., Yang, X., Zimmerman, M. D., Gengenbacher, M., Dartois, V. A., Chui, W., Jackson, C. J., & Dick, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025172118 · Cited by 16
The past, present and future of tuberculosis treatment
Bi, K., Cao, D., Cheng, D. I. N. G., Lu, S., Lu, H., ZHANG, G., Zhang, W., Li, L., Xu, K., Li, L., et al. (2022) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2022-0454 · Cited by 16
Self-citationBroussy, S., Bernardes‐Génisson, V., Gornitzka, H., Bernadou, J., & Meunier, B. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b415439h · Cited by 16
Chaumontet, M., Pons, V., Fournel‐Marotte, K., & Prandi, J. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.12.029 · Cited by 16
Site‐directed mutagenesis and virulence assessment of the katG gene of Mycobacterium intracellulare
Marklund, B., Mahenthiralingam, E., & Stokes, R. W. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00982.x · Cited by 16
Kumari, M., Tiwari, N., Chandra, S., & Subbarao, N. (2018) · International Journal of Computational Biology and Drug Design · doi:10.1504/ijcbdd.2018.094630 · Cited by 17
Garcia, M. X. U., Roberts, C., Alexander, H., Stewart, A. M., Harwood, A. J., Alexander, S., & Insall, R. H. (2002) · Microbiology · doi:10.1099/00221287-148-1-333 · Cited by 16
Applications of Molecular Simulation in the Discovery of Antituberculosis Drugs: A Review
Hu, J., Wu, Z., Xie, T., Liu, X., Yan, X. H., Sun, X., Liu, W., Liang, L., He, G., Gan, Y., et al. (2019) · Protein and Peptide Letters · doi:10.2174/0929866526666190620145919 · Cited by 16
Benefits and limitations of pathology databases to cancer registries.
Brewster, D., Crichton, J., Harvey, J. C., Dawson, G., & Nairn, E. R. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.11.947 · Cited by 16
Mzibri, M. E., Zakham, F., Chaoui, I., Echchaoui, A. H., Chetioui, F., Messaoudi, M. D. E., Ennaji, M. M., & Abid, M. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s47724 · Cited by 15
Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
Chambial, P., Thakur, N., Bhukya, P. L., Anbazhagan, S., & Kumar, U. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04262-x · Cited by 22
POLYMERASE CHAIN REACTION AND ADVANCES IN INFECTIOUS DISEASE DIAGNOSIS
MENON, P., Kapila, K., & Ohri, V. C. (1999) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(17)30450-1 · Cited by 15
Raghunandanan, S., Jose, L., & Kumar, R. A. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0098-z · Cited by 15
Mourer, M., Duval, R. E., Constant, P., Daffé, M., & Regnouf‐de‐Vains, J. (2018) · ChemBioChem · doi:10.1002/cbic.201800609 · Cited by 15
Franco-Sotomayor, G., Garzón-Chávez, D., León-Benítez, M., de Waard, J. H., & García-Bereguiain, M. Á. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0203 · Cited by 15
Prokaryotic Peroxidases and Their Application in Biotechnology (Review)
Khmelevtsova, L. E., Sazykin, I. S., Azhogina, T. N., & Sazykina, M. A. (2020) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683820030059 · Cited by 15
Iron enhances the susceptibility of pathogenic mycobacteria to isoniazid, an antitubercular drug
Sritharan, M., Yeruva, C. V., Sivasailappan, S. C., & Duggirala, S. (2006) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-006-9183-8 · Cited by 16
Tuberculosis in the context of emerging and reemerging diseases
Brennan, P. J. (1997) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(97)00056-4 · Cited by 22
Is the isonicotinoyl radical generated during activation of isoniazid by MnIII-pyrophosphate?
Nguyen, M., Claparols, C., Bernadou, J., & Meunier, B. (2002) · Comptes Rendus Chimie · doi:10.1016/s1631-0748(02)01370-x · Cited by 15
More, U. A., Joshi, S. D., Aminabhavi, T. M., Kulkarni, V. H., Badiger, A. M., & Lherbet, C. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.03.013 · Cited by 15
Dantes, R., Metcalfe, J. Z., Kim, E., Kato‐Maeda, M., Hopewell, P. C., Kawamura, M., Nahid, P., & Cattamanchi, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037956 · Cited by 16
Nanocarrier-based interventions for the management of MDR/XDR-TB
Mustafa, S., Pai, R. S., Singh, G., & Devi, V. K. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1009076 · Cited by 15
Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test
Choi, S. W., Maïga, M., Maiga, M. C., Atudorei, V. N., Sharp, Z. D., Bishai, W. R., & Timmins, G. S. (2014) · Nature Communications · doi:10.1038/ncomms5989 · Cited by 15
Yamashiro, L. H., Eto, C., Soncini, M. D., Horewicz, V. V., Garcia, M., Schlindwein, A. D., Grisard, E. C., Rovaris, D. B., & Báfica, A. L. B. (2016) · European Journal of Immunology · doi:10.1002/eji.201646349 · Cited by 16
Talbot, E. A., & Raffa, B. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00092-5 · Cited by 15
Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis
Frolova, S. G., Klimina, K. M., Kumar, R., Vatlin, A. A., Salunke, D. B., Kendrekar, P. S., Даниленко, В. Н., & Maslov, D. A. (2020) · Antibiotics · doi:10.3390/antibiotics10010006 · Cited by 15
Eiglmeier, K., Fsihi, H., Heym, B., & Cole, S. T. (1997) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb10340.x · Cited by 15
Self-citationNotes on an Evolutionary Medicine
Weiner, H. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199807000-00020 · Cited by 15
Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012
Spinato, J., Boivin, É., Bélanger-Trudelle, É., Fauchon, H., Tremblay, C. L., & Soualhine, H. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0786-4 · Cited by 15
Wiseman, B., Colin, J., SMITH, A. T., Ivancich, A., & Loewen, P. C. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0493-9 · Cited by 15
KANG, S., Lee, J. H., Lee, Y., & Kim, C. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.026 · Cited by 15
Miller, B. H., & Shinnick, T. M. (2001) · BMC Microbiology · doi:10.1186/1471-2180-1-26 · Cited by 19
Zhang, Z., Rusling, J. F., Chouchane, S., & Magliozzo, R. S. (2001) · Chemical Communications · doi:10.1039/b009348n · Cited by 15
The Mycobacterium tuberculosis katG promoter region contains a novel upstream activator
Mulder, M. A., Zappe, H., & Steyn, L. M. (1999) · Microbiology · doi:10.1099/00221287-145-9-2507 · Cited by 18
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay
Miyamoto, J., Koga, H., KOHNO, S., Tashiro, T., & Hara, K. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.5.1323-1326.1996 · Cited by 15
Radhakrishnan, S. K., & Sundaramurthy, V. (2026) · mBio · doi:10.1128/mbio.03959-25 · Cited by 14
Drug-Resistant Tuberculosis: Pediatric Guidelines
Devi, N. P. G., & Swaminathan, S. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0363-z · Cited by 14
Designing and testing single tablet for tuberculosis treatment through electrospinning
Hassounah, I., Shehata, N., Kimsawatde, G. C., Hudson, A. G., Sriranganathan, N., Joseph, E. G., & Mahajan, R. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-41533-0.00011-8 · Cited by 17
Cao, B., Mijiti, X., Deng, L., Wang, Q., Yu, J.-J., Anwaierjiang, A., Qian, C., Li, M., Fang, D., Jiang, Y., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s407525 · Cited by 14
Dibama, H. M., Mourer, M., Constant, P., Daffé, M., & Regnouf‐de‐Vains, J. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.053 · Cited by 14
Jalava, J., & Marttila, H. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm11211-1209.x · Cited by 15
Allegui, Z., Ghariani, A., Draoui, H., Ghezal, A., Mehiri, E., & Slim-Saidi, L. (2012) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2012.01.006 · Cited by 14
Crystal Structure and Comparative Functional Analyses of a Mycobacterium Aldo-Keto Reductase
Scoble, J. A., McAlister, A. D., Fulton, Z., Troy, S., Byres, E., Vivian, J. P., Brammananth, R., Wilce, M. C. J., Nours, J. L., Zaker-Tabrizi, L., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.02.021 · Cited by 16
da Costa, A. L. P., Pauli, I., Dorn, M., SCHROEDER, E., Zhan, C., & de Souza, O. N. (2011) · Journal of Molecular Modeling · doi:10.1007/s00894-011-1200-7 · Cited by 14
Unissa, A. N., Sukumar, S., & Hanna, L. E. (2017) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2017.80.3.255 · Cited by 14
Jaladanki, C. K., Shaikh, A. A., & Bharatam, P. V. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00129 · Cited by 14
Nyinoh, I. W., & McFadden, J. (2018) · Drug Development Research · doi:10.1002/ddr.21497 · Cited by 14
Verma, R., Boshoff, H. I., Arora, K., Bairy, I., Tiwari, M., Varadaraj, B. G., & Shenoy, G. G. (2019) · Drug Development Research · doi:10.1002/ddr.21623 · Cited by 14
Hazari, P. P., Chuttani, K., Kumar, N., Mathur, R., Sharma, R., Singh, B., & Mishra, A. K. (2009) · The Open Nuclear Medicine Journal · doi:10.2174/1876388x00901010033 · Cited by 14
Dutt, A. K., & Stead, W. W. (1997) · Disease-a-Month · doi:10.1016/s0011-5029(97)90023-7 · Cited by 14
Powers, L. S., Hillar, A., & Loewen, P. C. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00221-1 · Cited by 14
Mulder, M. A., Nair, S., Abratt, V. R., Zappe, H., & Steyn, L. M. (1999) · Microbiology · doi:10.1099/13500872-145-8-2011 · Cited by 14
Caws, M., Tho, D. Q., Phan, M., Lan, N. T. N., Hoa, D. V., Török, M. E., Chau, T. T. H., Châu, N. V. V., Chinh, N. T., & Farrar, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01960-06 · Cited by 19
Riaz, M., Mahmood, Z., Javed, M. T., Javed, I., Shahid, M. A., Abbas, M., & Ehtisham-ul-Haque, S. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016638100 · Cited by 14
Andrade, C. H., Pasqualoto, K. F. M., Zaim, M. H., & Ferreira, E. I. (2008) · Revista Brasileira De Ciencias Farmaceuticas · doi:10.1590/s1516-93322008000200002 · Cited by 14
Extra and intracellular expression of Mycobacterium tuberculosis genes
Smith, I., Dussurget, O., Rodríguez, G. M., Timm, J., Gomez, M., Dubnau, J., Gold, B., & Manganelli, R. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0010 · Cited by 14
Carpena, X., Switala, J., Loprasert, S., Mongkolsuk, S., Fita, I., & Loewen, P. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902017869 · Cited by 14
Application of antimicrobial drugs in Mycobacterium tuberculosis and research progress
Wang, Y., Cao, D., & Liu, G. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107794 · Cited by 13
Dual oxidase 1 is dispensable during Mycobacterium tuberculosis infection in mice
Gupta, T., Sarr, D., Fantone, K. M., Ashtiwi, N. M., Sakamoto, K., Quinn, F. D., & Rada, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1044703 · Cited by 13
Punkvang, A., Saparpakorn, P., Hannongbua, S., Wolschann, P., Berner, H., & Pungpo, P. (2010) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-010-0359-4 · Cited by 13
Molecular Details of INH-C10 Binding to wt KatG and Its S315T Mutant
Teixeira, V. H., Ventura, C. M., Elvas‐Leitão, R., Ràfols, C., Bosch, E., Martins, F. E. L., & Machuqueiro, M. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500736n · Cited by 13
Machuqueiro, M., Victor, B. L., Switala, J., Villanueva, J., Rovira, C., Fita, I., & Loewen, P. C. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01276 · Cited by 13
Drug resistant tuberculosis: Current scenario and impending challenges
Dewhare, S. S. (2021) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2021.04.008 · Cited by 13
In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv
Dokrungkoon, T., Tulyaprawat, O., Suwannakarn, K., & Ngamskulrungroj, P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1171861 · Cited by 13
Drug resistance prediction for Mycobacterium tuberculosis with reference graphs
Hall, M. B., Lima, L., Coin, L., & Iqbal, Z. (2023) · Microbial Genomics · doi:10.1099/mgen.0.001081 · Cited by 13
An update on pathogenesis and management of tuberculosis with special reference to drug resistance
Bhunia, S. K., Sarkar, M., Banerjee, A., & Giri, B. (2015) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(15)60912-4 · Cited by 13
Metadata
- Authors
- Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S.
- Affiliations
- Hammersmith Hospital (GB)
- Institut Pasteur (FR)
- Venue
- Nature
- Published
- 1992-08-13
- Volume
- 358
- Issue
- 6387
- Pages
- 591-593
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2058925610
- Cited by
- 1,299
- References
- 17
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 28 · 2023: 26 · 2022: 35 · 2021: 34 · 2020: 47 · 2019: 45 · 2018: 49 · 2017: 50 · 2016: 36 · 2015: 47 · 2014: 69 · 2013: 37 · 2012: 50
- FWCI
- 37.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- isoniazid resistance, Mycobacterium tuberculosis, katG gene, catalase-peroxidase, multidrug resistance, Mycobacterium smegmatis, Escherichia coli, gene deletion, antitubercular agents, tuberculosis
- MeSH terms
- Amino Acid Sequence, Bacterial Proteins, Base Sequence, Catalase, Cloning, Molecular, DNA, Bacterial, Drug Resistance, Microbial, Escherichia coli, Genes, Bacterial, Isoniazid, Molecular Sequence Data, Mutation, Mycobacterium tuberculosis, Peroxidases, Plasmids, Blotting, Southern, Restriction Mapping, Oligonucleotide Probes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.